Dr. Naveen Vairamoorthy

• MBBS: Government Thanjavur Medical College, Thanjavur, Tamil Nadu, 2012
• MD (Pathology): Seth GS Medical College & KEM Hospital, Mumbai, 2017
• DipRCPath (Hematology): Royal College of Pathologists, London, UK, 2021
• DrNB (Clinical Hematology): Sir Ganga Ram Hospital, New Delhi, 2025
• Member: British Society for Hematology, since 2021
• Member: European Hematology Association, since 2025

Current Roles & Expertise

Dr.  Naveen Vairamoorthy practices at a cellular therapy centre, contributing across the CAR T pathway: patient selection, bridging therapy coordination, inpatient/outpatient management, toxicity recognition and management (CRS, ICANS), and survivorship follow-up. Parallel laboratory leadership includes ISO 15189-aligned quality management, SOP authorship/revision, and EQA performance oversight. Dr.  Naveen Vairamoorthy supervises junior trainees, leads MDT discussions, and supports protocol development in hemato-oncology.

Key Clinical & Procedural Experience

• Part of 180+ hematopoietic stem cell transplantations
• 250+ bone marrow/trephine biopsies independently performed (reported under supervision)
• 150+ lumbar punctures including intrathecal chemotherapy
• PICC line insertions and removal of tunneled catheters
• Day-care chemotherapy, transfusion support, and complex inpatient hemato-oncology care
• Flow cytometry interpretation, advanced morphology, and integration of molecular diagnostics

Teaching & Educational Leadership

• Recognised undergraduate teacher (NMC faculty database)
• Developed 12+ haematopathology modules with digital microscopy and simulation
• Led OSCE delivery and examiner roles; transitioned teaching to virtual platforms during the pandemic
• Consistently high learner feedback (≈4.7/5), mentoring junior doctors and technical staff

Areas of Special Interest

• Cellular therapy: Pathways, toxicity management, survivorship
• Diagnostic integration: Flow cytometry, NGS-informed reporting in MDS/MPN
• Quality systems: ISO 15189 accreditation, EQA optimisation, audit-to-change cycles
• Data & digital: R-based analysis, LaTeX scientific writing, Linux scripting for reproducible research
• Teaching innovation: Digital curricula, simulation, learner-centred assessment

• National level hematology quiz – third prize, 2024
• Certificate of appreciation (COVID-19 Response), Government of India, 2021
• Second best paper in hematology, MAPCON, 2016
• Research and travel grant recognitions at regional and international meetings

Selected Quality Improvement & Change Projects

• Neutropenic Fever Pathway (Research-to-Practice) Implemented a procalcitonin-based pathway for febrile neutropenia, reducing unnecessary antibiotic exposure and improving decision timelines through MDT training and protocol updates.
• Reflex Testing Pathways in MPN/MDSDesigned criteria-led reflex algorithms for molecular testing to optimise resource use and shorten turnaround times.
• ISO 15189 Accreditation & SOP GovernanceLed internal audits, CAPA cycles, and SOP lifecycle management supporting successful accreditation/reaccreditation.

Selected Projects

• Procalcitonin Versus CRP in Febrile Neutropenia: Demonstrated superior performance of procalcitonin for detecting MDR Gram-negative bacteraemia and informed a new departmental pathway.
• Activated Cytotoxic T-Cell Phenotyping in Adult HLH: Identified a practical, flow-based activation threshold warranting validation as a diagnostic adjunct.

Selected Presentations

• Procalcitonin and CRP as Predictors of Bacteraemia in Neutropenic Fever – Asia-Pacific BMT Conference, 2024
• Invasive Fungal Infections: Clinical Profile and Outcomes – hematologymatocon, 2024
• Front-line Azacitidine and Venetoclax combination in Acute Myeloid Leukaemia – hematologymatocon, 2024
• Relapsed Severe Aplastic Anaemia: Second Course Horse ATG – hematologymatocon, 2023